Improving sleep in adults with cannabis use issues
Official title: Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use
Run by University of Michigan · NCT05814822 · Data updated 2026-11-12
This study is testing whether a special online therapy for sleep problems can help adults who use cannabis for sleep feel better and sleep more soundly compared to regular sleep education.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT05814822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with chronic insomnia who use cannabis at least three times a week to manage their sleep issues.
✕Probably not a fit
Patients with other significant sleep disorders or severe mental health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the effectiveness of telemedicine-delivered cognitive behavioral therapy for insomnia specifically designed for individuals using cannabis for sleep against telemedicine-delivered sleep hygiene education. It aims to assess improvements in sleep quality, cannabis use, and daytime functioning. Additionally, the study will evaluate the impact of the cognitive behavioral therapy on the body's sleep regulatory system and its correlation with clinical outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved sleep quality and reduced cannabis dependency for patients struggling with insomnia.
How similar studies have gone: Other studies have shown promising results with cognitive behavioral therapy for insomnia, suggesting potential success for this tailored approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA * 21 years of age and older, the age needed to obtain full legal access to cannabis in Michigan * Self-reported chronic insomnia (nighttime symptoms of difficulty initiating and/or maintaining sleep and/or early morning awakenings on ≥3 nights for ≥3 months with daytime impairment), consistent with DSM-5 diagnosis of Insomnia Disorder * Insomnia Severity Index (ISI) score ≥11, indicative of at least "mild" insomnia * A positive urine drug screen (UDS) for cannabis33 * Self-reported use of cannabis at least three times weekly for the past month * Stable residence (e.g., stable sleep arrangements), consistent access to Wi-Fi, and ability to travel to Ann Arbor for sleep laboratory assessments EXCLUSION CRITERIA * Individuals who do not understand English (read and spoken) * Individuals judged unable to provide informed consent (e.g., intoxication, mental incompetence) * Diagnosis or high suspicion of a sleep disorder other than insomnia * Lifetime diagnosis of psychotic disorder or bipolar disorder; current post-traumatic stress disorder that directly interferes with sleep * Terminal or progressive physical illness (e.g., cancer) or neurological degenerative disease (e.g., dementia) * Use of medications known to have initiated their insomnia (e.g., steroids) * Previous receipt of CBTi * Self-reported pregnancy * Self-reported regular work schedule of rotating or night (3rd) shift work * Other conditions and situations, medical or otherwise, that preclude meaningful and/or safe participation in CNT/SHE and study procedures
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Principal investigator: Todd Arnedt, PhD — University of Michigan
- Study coordinator: Libby Cardoni
- Email: mehobson@med.umich.edu
- Phone: 734.764.7175
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.